Faculty:
Alice T. Epitropoulos, MD, FACS
Ophthalmic Surgeons and Consultants of Ohio
The Eye Center of Columbus
Clinical Assistant Professor
The Ohio State University Medical Center
Columbus, OH
Reviewer:
Terry Kim, MD
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
The contents of this activity derives from Hawaiian Eye 2016 which took place on January 16-22, 2016. Disclosures for faculty are accurate as of the time of the live meeting.
Faculty member reports the following relationship(s):
Alice T. Epitropoulos, MD, FACS
Consulting Fees:Allergan, Inc., Bausch + Lomb, Inc., Shine Pharmaceuticals Ltd.
Receipt of Intellectual Property Rights: Alice Epitropoulos MD/Epico, LLC
Consulting Fee: Allergan, Bausch + Lomb, Shire Pharmaceuticals Ltd.
Speakers Bureau: Allergan, Inc., Bausch + Lomb, Inc., TearScience
Fees for Non-CE Services: Allergan, Bausch + Lomb, Nicox; TearScience
Contracted Research: Bausch + Lomb, Physician Recommended Nutriceuticals, TearLab
Reviewer reports the following relationship(s):
Terry Kim, MD
Consulting Fee: Acucela, Acuity Advisors, Aerie, Alcon, Allergan/Actavis, Bausch + Lomb/Valeant, CoDa Therapeutics, Foresight, Kala, NovaBay, Ocular Systems, Ocular Therapeutix, Oculeve, Omeros, Powervision, Presbyopia, Shire, Stealth BioTherapeutics, TearLab, TearScienc
Speakers Bureau: Alcon, Allergan, Bausch + Lomb/Valeant, Omeros, Shire
Ownership Interest: CoDa Therapuetics, NovaBay, Ocular Therapeutix, Omeros, Powervision, Presbyopia
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.